Intellia Therapeutics, Inc. (NTLA) vs Zenas BioPharma, Inc. (ZBIO)
- Intellia Therapeutics, Inc. NTLA 11.42 +0.71%
- Zenas BioPharma, Inc. ZBIO 24.67 −2.87%
Intellia Therapeutics, Inc. and Zenas BioPharma, Inc. are both Biotechnology companies. Intellia Therapeutics, Inc. and Zenas BioPharma, Inc. are of similar size ($1.7B and $1.6B). Zenas BioPharma, Inc. has the higher net margin (0.00% vs −672.2%) and the higher return on invested capital (0.00% vs −91.3%). Across the 13 metrics below, Zenas BioPharma, Inc. leads on 8 and Intellia Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | NTLA | ZBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | (711.66%) | 0.00% | 0.00% |
| Net margin | (672.16%) | 0.00% | 0.00% |
| Free cash flow margin | (585.82%) | 0.00% | 0.00% |
| Return on equity | (55.44%) | (199.04%) | (56.36%) |
| Return on assets | (45.55%) | (97.39%) | (48.04%) |
| Return on invested capital | (91.28%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack